Global Information
회사소개 | 문의

세계의 지노타이핑(유전자형 결정) 어세이 시장 예측(2023년) : 중합효소 연쇄 반응(PCR), 시퀀싱, 마이크로어레이, 전기영동법, MALDI-TOF법

Genotyping Assay Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023

리서치사 MarketsandMarkets
발행일 2018년 11월 상품 코드 330495
페이지 정보 영문 281 Pages
가격
US $ 5,650 ₩ 6,437,600 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,577,000 PDF by E-mail (5-User License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,286,100 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,394,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 지노타이핑(유전자형 결정) 어세이 시장 예측(2023년) : 중합효소 연쇄 반응(PCR), 시퀀싱, 마이크로어레이, 전기영동법, MALDI-TOF법 Genotyping Assay Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023
발행일 : 2018년 11월 페이지 정보 : 영문 281 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 지노타이핑(유전자형 결정 : Genotyping Assay) 시장은 2018년의 118억 달러에서 2023년까지 319억 달러에 달할 것으로 예측되고, 22.0%의 CAGR(연간 복합 성장률)로 성장하며 2020년에 170억 달러에 달할 것으로 예측됩니다. 기술 진보, DNA 시퀀싱의 가격 하락 및 유전병 발증률의 증가 등은 세계 지노타이핑 시장의 성장을 촉진할 것으로 예측됩니다. 그러나 장비의 고비용은 예측 기간 중 이 시장의 성장을 다소 억제할 전망입니다.

세계의 지노타이핑(유전자형 결정) 시장에 대해 조사했으며, 시장 개요와 산업구조, 제품 & 서비스·기술·용도·최종사용자·지역별 시장 분석, 시장 성장에 대한 각종 영향요인과 시장 기회 분석, 경쟁 환경과 시장 점유율 및 주요 기업 개요 등을 정리하여 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 개요

제4장 프리미엄 인사이트

  • 지노타이핑 시장의 개요
  • 아시아태평양의 지노타이핑 시장 : 제품 & 서비스별, 국가별
  • 지노타이핑 시장의 지역 개요
  • 지역 믹스 : 지노타이핑 시장
  • 지노타이핑 시장 : 개발도상 시장 vs. 선진 시장

제5장 시장 개요

  • 서론
  • 시장 역학 : 영향 분석
  • 시장 성장 촉진요인
  • 시장 성장 저해요인
  • 시장 기회
  • 시장이 해결해야 할 과제

제6장 산업 인사이트

  • 산업 동향
  • 규제 분석
  • 전략적 벤치마킹

제7장 지노타이핑 시장 : 제품 & 서비스별

  • 서론
  • 시약 & 키트
  • 지노타이핑 서비스
  • 장비
    • 시퀸서 & 증폭기
    • 애널라이저
  • 바이오인포매틱스
    • 소프트웨어
    • 서비스

제8장 지노타이핑 시장 : 기술별

  • 서론
  • 중합효소 연쇄 반응(PCR)
    • 실시간 PCR
    • 디지털 PCR
  • 마이크로어레이
  • 시퀀싱
    • 차세대 시퀀싱(NGS)
    • 파이로시퀀싱(PYROSEQUENCING)
    • 생어 시퀀싱(SANGER SEQUENCING)
  • 모세관 전기영동법
    • AFLP(AMPLIFIED FRAGMENT LENGTH POLYMORPHISM)
    • RFLP(RESTRICTION FRAGMENT LENGTH POLYMORPHISM)
    • SSCP(SINGLE-STRAND CONFORMATION POLYMORPHISM)
  • MALDI-TOF(MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT)
  • 기타

제9장 지노타이핑 시장 : 용도별

  • 서론
  • 약물유전체학
  • 진단 & 맞춤형 의료
  • 동물 유전학
  • 농업 바이오테크놀러지
  • 기타

제10장 지노타이핑 시장 : 최종사용자별

  • 서론
  • 의약품 & 바이오의약품 기업
  • 진단 & 연구소
  • 학술기관
  • 기타

제11장 지노타이핑 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제12장 경쟁 환경

  • 개요
  • 제품 포트폴리오 매트릭스
  • 시장 점유율 분석
  • 경쟁 구도·동향

제13장 기업 개요

  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • ROCHE DIAGNOSTICS LIMITED
  • QIAGEN N.V.
  • DANAHER CORPORATION
  • AGILENT TECHNOLOGIES, INC.
  • FLUIDIGM CORPORATION
  • GE HEALTHCARE
  • GENEWIZ, INC.
  • INTEGRATED DNA TECHNOLOGIES, INC.(DANAHER CORPORATION 자회사)
  • PERKINELMER, INC.
  • BIO-RAD LABORATORIES, INC.
  • EUROFINS SCIENTIFIC
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

제14장 부록

KSA 18.12.03

LIST OF TABLES

  • TABLE 1: STANDARD CURRENCY CONVERSION RATES
  • TABLE 2: GENOTYPING MARKET SNAPSHOT, 2018 VS. 2023
  • TABLE 3: COMPARATIVE DATA: OLDER VS LATEST PLATFORMS, BY COMPANY
  • TABLE 4: RECENT DEVELOPMENTS IN THE GENOTYPING MARKET
  • TABLE 5: CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 6: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 7: GENOTYPING REAGENTS & KITS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: GENOTYPING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 9: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: GENOTYPING INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: GENOTYPING SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: GENOTYPING ANALYZERS MARKET, BY COUNTRY, 2016-2023 ( USD MILLION)
  • TABLE 13: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023, (USD MILLION)
  • TABLE 14: GENOTYPING BIOINFORMATICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 15: GENOTYPING BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: GENOTYPING BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 18: COMPARATIVE STUDY: REAL-TIME PCR VS DIGITAL PCR
  • TABLE 19: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 20: POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: MAJOR REAL-TIME PCR PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 22: REAL-TIME PCR MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: MAJOR DIGITAL PCR PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 24: DIGITAL PCR MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: MAJOR MICROARRAY PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 26: MICROARRAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 28: SEQUENCING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: MAJOR NEXT-GENERATION SEQUENCING PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 30: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 31: MAJOR PYROSEQUENCING PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 32: PYROSEQUENCING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: MAJOR SANGER SEQUENCING PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 34: SANGER SEQUENCING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 36: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: MAJOR AFLP PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 38: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 39: MAJOR RFLP PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 40: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 41: MAJOR SSCP PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 42: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 43: MAJOR MALDI-TOF PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 44: MALDI-TOF MASS SPECTROMETRY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 45: MAJOR PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 46: GENOTYPING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 47: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 48: GENOTYPING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: GENOTYPING MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 50: GENOTYPING MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: GENOTYPING MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 52: GENOTYPING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 54: GENOTYPING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 55: GENOTYPING MARKET FOR DIAGNOSTIC AND RESEARCH LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 56: GENOTYPING MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 57: GENOTYPING MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 58: GENOTYPING MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 59: NORTH AMERICA: GENOTYPING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 61: NORTH AMERICA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: NORTH AMERICA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: NORTH AMERICA: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 64: NORTH AMERICA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 65: NORTH AMERICA: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 67: NORTH AMERICA: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 68: NORTH AMERICA: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 69: US: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 70: US: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: US: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 72: US: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 73: US: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: US: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: US: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: US: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 77: US: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 78: CANADA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 79: CANADA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: CANADA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: CANADA: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 82: CANADA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: CANADA: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 84: CANADA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 85: CANADA: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 86: CANADA: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 87: EUROPE: GENOTYPING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 88: EUROPE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 89: EUROPE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: EUROPE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: EUROPE: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 92: EUROPE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: EUROPE: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 95: EUROPE: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 96: EUROPE: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 97: GERMANY: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 98: GERMANY: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: GERMANY: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 100: GERMANY: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 101: GERMANY: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: GERMANY: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: GERMANY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 104: GERMANY: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 105: GERMANY: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 106: FRANCE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 107: FRANCE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: FRANCE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: FRANCE: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 110: FRANCE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: FRANCE: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: FRANCE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 113: FRANCE: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 114: FRANCE: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 115: UK: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 116: UK: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: UK: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: UK: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 119: UK: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 120: UK: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: UK: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: UK: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 123: UK: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 124: ITALY: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 125: ITALY: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 126: ITALY: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 127: ITALY: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 128: ITALY: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 129: ITALY: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 130: ITALY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 131: ITALY: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 132: ITALY: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 133: SPAIN: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 134: SPAIN: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 135: SPAIN: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 136: SPAIN: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 137: SPAIN: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 138: SPAIN: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 139: SPAIN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 140: SPAIN: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 141: SPAIN: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 142: ROE: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 143: ROE: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 144: ROE: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 145: ROE: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 146: ROE: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 147: ROE: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: ROE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 149: ROE: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 150: ROE: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 151: APAC: GENOTYPING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 152: APAC: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 153: APAC: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 154: APAC: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 155: APAC: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 156: APAC: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 157: APAC: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 158: APAC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 159: APAC: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 160: APAC: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 161: CHINA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 162: CHINA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: CHINA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: CHINA: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 165: CHINA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 166: CHINA: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 167: CHINA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 168: CHINA: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 169: CHINA: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 170: JAPAN: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 171: JAPAN: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 172: JAPAN: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: JAPAN: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 174: JAPAN: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 175: JAPAN: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 176: JAPAN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 177: JAPAN: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 178: JAPAN: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 179: INDIA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 180: INDIA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 181: INDIA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 182: INDIA: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 183: INDIA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 184: INDIA: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 185: INDIA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 186: INDIA: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 187: INDIA: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 188: ROAPAC: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 189: ROAPAC: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 190: ROAPAC: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 191: ROAPAC: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 192: ROAPAC: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 193: ROAPAC: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 194: ROAPAC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 195: ROAPAC: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 196: ROAPAC: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 197: LATIN AMERICA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 198: LATIN AMERICA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 199: LATIN AMERICA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 200: LATIN AMERICA: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 201: LATIN AMERICA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 202: LATIN AMERICA: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 203: LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 204: LATIN AMERICA: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 205: LATIN AMERICA: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 206: MEA: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 207: MEA: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 208: MEA: GENOTYPING BIOINFORMATICS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 209: MEA: GENOTYPING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 210: MEA: POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 211: MEA: SEQUENCING MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 212: MEA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 213: MEA: GENOTYPING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 214: MEA: GENOTYPING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 215: GROWTH STRATEGY MATRIX (2015-2018)
  • TABLE 216: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, 2015-2018
  • TABLE 217: COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2015-2018
  • TABLE 218: ACQUISITIONS, 2015-2018
  • TABLE 219: EXPANSIONS, 2015-2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: PRIMARY SOURCES
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GENOTYPING MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: GENOTYPING INSTRUMENTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: BIOINFORMATICS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: GENOTYPING MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: PCR MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: SEQUENCING MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 12: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 13: GENOTYPING MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 14: GENOTYPING MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 15: GENOTYPING MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 16: TECHNOLOGICAL ADVANCEMENTS AND DECREASING PRICES OF DNA SEQUENCING ARE DRIVING MARKET GROWTH
  • FIGURE 17: REAGENTS & KITS COMMANDED THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 18: THE US ACCOUNTED FOR THE LARGEST SHARE OF THE GENOTYPING MARKET IN 2017
  • FIGURE 19: ASIA PACIFIC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 20: DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: COMPARATIVE ANALYSIS OF HUMAN WHOLE-GENOME SEQUENCING COST AND AMOUNT OF DATA PRODUCED PER GENOME (2001-2017)
  • FIGURE 22: FDA 510(K) APPROVAL PROCESS
  • FIGURE 23: EUROPE: CLASSIFICATION OF GENOTYPING PRODUCTS
  • FIGURE 24: REGULATORY PROCESS FOR GENOTYPING PRODUCTS IN JAPAN
  • FIGURE 25: INDIA: REGULATORY PROCESS FOR GENOTYPING PRODUCTS
  • FIGURE 26: REAGENTS & KITS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 27: SEQUENCERS & AMPLIFIERS SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE GENOTYPING INSTRUMENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: SOFTWARE SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE GENOTYPING BIOINFORMATICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 29: SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 30: REAL-TIME PCR SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2023
  • FIGURE 31: NGS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 32: AFLP SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 33: PHARMACOGENOMICS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 34: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO WITNESS THE HIGHEST GROWTH RATE IN THE GENOTYPING MARKET DURING THE FORECAST PERIOD
  • FIGURE 35: GEOGRAPHICAL SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS
  • FIGURE 36: NORTH AMERICA: GENOTYPING MARKET SNAPSHOT
  • FIGURE 37: EUROPE: GENOTYPING MARKET SNAPSHOT
  • FIGURE 38: APAC: GENOTYPING MARKET SNAPSHOT
  • FIGURE 39: KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2015 AND MARCH 2018
  • FIGURE 40: GENOTYPING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 41: PRODUCT LAUNCHES, APPROVALS, & ENHANCEMENTS WAS THE KEY GROWTH STRATEGY ADOPTED BY MAJOR PLAYERS BETWEEN 2015 & 2018
  • FIGURE 42: ILLUMINA, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 43: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 44: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2017)
  • FIGURE 45: QIAGEN N.V.: COMPANY SNAPSHOT (2017)
  • FIGURE 46: DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 47: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017)
  • FIGURE 48: FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 49: GE HEALTHCARE: COMPANY SNAPSHOT (2017)
  • FIGURE 50: PERKINELMER, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 51: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 52: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 53: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2017)

"The global genotyping market is projected to grow at a CAGR of 22.0%."

The genotyping market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%. Technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases are expected to drive the growth of the global genotyping market. However, the high cost of equipment is expected to restrain market growth to a certain extent during the forecast period.

"Pharmacogenomics application segment to witness the highest growth during the forecast period."

On the basis of application, the genotyping market is segmented into pharmacogenomics, diagnostic & personalized medicine, agricultural biotechnology, animal genetics, and other applications. The pharmacogenomics segment is expected to register the highest CAGR during the forecast period. The increased use of genotyping to predict the efficiency of drugs during drug development and the growing need to understand the adverse effects of drugs are the major factors driving the growth of this market segment.

"Pharmaceutical and biopharmaceutical companies end-user segment is expected to grow at the highest CAGR during the forecast period."

On the basis of end user, the genotyping market is segmented into pharmaceutical & biopharmaceutical companies, diagnostic & research institutes, academic institutes, and other end users. The pharmaceutical & biopharmaceutical companies segment is expected to witness the highest CAGR owing to the growing importance of biomarkers in genotyping used among these end users, given their applications in drug development which, in turn, will support the growth of this segment.

"APAC is projected to witness the highest growth during the forecast period."

North America is expected to account for the largest share of the global genotyping market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing incidence of chronic diseases and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases & the spread of infectious and microbial diseases in APAC countries. The increasing outsourcing of clinical research and trials by pharmaceutical and biopharmaceutical companies to organizations in the APAC has driven the demand for genotyping products for drug profile assessment, drug efficacy, safety assessment, dosing determination, and drug response evaluation.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-46%, Tier 2-33%, and Tier 3-21%
  • By Designation: C-level-43%, Director Level-35%, and Others-22%
  • By Region: North America-34%, Europe-26%, Asia Pacific-19%, Latin America-11%, and the Middle East & Africa-10%

The prominent players in the global genotyping market are: Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

Research Coverage:

The report analyzes the market for various genotyping products and their adoption pattern. It aims at estimating the market size and future growth potential of the global genotyping market and different segments such as products, technology, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global genotyping market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global genotyping market
  • Market Development: Comprehensive information on the lucrative emerging regions by product, technology, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global genotyping market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global genotyping market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. MARKET SEGMENTATION, BY REGION
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GENOTYPING MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: GENOTYPING MARKET, BY PRODUCT & SERVICE, BY COUNTRY, 2017
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE GENOTYPING MARKET
  • 4.4. GEOGRAPHIC MIX: GENOTYPING MARKET
  • 4.5. GENOTYPING MARKET: DEVELOPING VS. DEVELOPED MARKETS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS: IMPACT ANALYSIS
  • 5.3. MARKET DRIVERS
    • 5.3.1. TECHNOLOGICAL ADVANCEMENTS AND DECREASING PRICES OF DNA SEQUENCING
    • 5.3.2. INCREASING INCIDENCE OF GENETIC DISEASES AND RISING AWARENESS ON PERSONALIZED MEDICINE
    • 5.3.3. GROWING IMPORTANCE OF GENOTYPING IN DRUG DEVELOPMENT
    • 5.3.4. INCREASING DEMAND FOR BIOINFORMATICS SOLUTIONS IN DATA ANALYSIS
  • 5.4. MARKET RESTRAINTS
    • 5.4.1. HIGH COST OF EQUIPMENT USED IN GENOTYPING
  • 5.5. MARKET OPPORTUNITIES
    • 5.5.1. GROWING IMPORTANCE OF SEQUENCING PROJECTS
    • 5.5.2. INCREASING APPLICATION AREAS OF GENOTYPING
    • 5.5.3. INCREASING DEMAND FOR GENOME ANALYSIS IN PLANT AND ANIMAL LIVESTOCK
  • 5.6. MARKET CHALLENGES
    • 5.6.1. DATA MANAGEMENT IN GENOTYPING RESEARCH
    • 5.6.2. DEARTH OF TRAINED RESOURCES

6. INDUSTRY INSIGHTS

  • 6.1. INDUSTRY TRENDS
    • 6.1.1. INCREASING DEMAND FOR GENOTYPING & SEQUENCING SERVICES
    • 6.1.2. INCREASING COLLABORATIONS
    • 6.1.3. INCREASING AWARENESS
  • 6.2. REGULATORY ANALYSIS
    • 6.2.1. US
    • 6.2.2. EUROPE
    • 6.2.3. JAPAN
    • 6.2.4. CHINA
    • 6.2.5. INDIA
  • 6.3. STRATEGIC BENCHMARKING
    • 6.3.1. GENOTYPING MARKET: PRODUCT PORTFOLIO ANALYSIS (INSTRUMENTS & KITS)
    • 6.3.2. GENOTYPING MARKET: PRODUCT PORTFOLIO ANALYSIS (BIOINFORMATICS)

7. GENOTYPING MARKET, BY PRODUCT & SERVICE

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS & KITS
    • 7.2.1. REAGENTS & KITS ACCOUNTED FOR THE LARGEST SHARE OF THE GENOTYPING MARKET IN 2017
  • 7.3. GENOTYPING SERVICES
    • 7.3.1. INCREASING DEMAND FOR SEQUENCING AND GENOTYPING SERVICES FROM HOSPITALS, SMALL- AND MEDIUM-SIZED RESEARCH CENTERS, AND PHARMACEUTICAL COMPANIES TO DRIVE THE GROWTH OF THIS SEGMENT
  • 7.4. INSTRUMENTS
    • 7.4.1. SEQUENCERS & AMPLIFIERS
      • 7.4.1.1. Sequencers & amplifiers segment to register the highest growth rate in the genotyping instruments market during the forecast period
    • 7.4.2. ANALYZERS
      • 7.4.2.1. Growing automation and advancements in analyzers with high-throughput capacities are the major factors driving market growth
  • 7.5. BIOINFORMATICS
    • 7.5.1. SOFTWARE
      • 7.5.1.1. Software segment accounted for the largest share of the genotyping bioinformatics market in 2017
    • 7.5.2. SERVICES
      • 7.5.2.1. Shortage of skilled bioinformatics professionals and the growing applications of bioinformatics in various industries are the major factors driving the growth of this segment

8. GENOTYPING MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. POLYMERASE CHAIN REACTION
    • 8.2.1. REAL-TIME PCR
      • 8.2.1.1. Real-time PCR dominated the PCR market in 2017, primarily due to the growing adoption of these instruments among researchers and healthcare professionals
    • 8.2.2. DIGITAL PCR
      • 8.2.2.1. The high cost of dPCR instruments to restrain the growth of this market
  • 8.3. MICROARRAYS
    • 8.3.1. INCREASING DEMAND FOR PERSONALIZED MEDICINE AND CONTINUOUS LAUNCH OF CUSTOM ARRAYS BY LEADING PLAYERS TO DRIVE MARKET GROWTH
  • 8.4. SEQUENCING
    • 8.4.1. NEXT-GENERATION SEQUENCING
      • 8.4.1.1. NGS to witness the highest growth rate in the sequencing market during the forecast period
    • 8.4.2. PYROSEQUENCING
      • 8.4.2.1. Growing demand for pyrosequencing by pharmaceutical and biotechnology companies to drive the adoption of this technology segment
    • 8.4.3. SANGER SEQUENCING
      • 8.4.3.1. Increasing use of this technology in small-scale experiments is the major factor driving market growth
  • 8.5. CAPILLARY ELECTROPHORESIS
    • 8.5.1. AMPLIFIED FRAGMENT LENGTH POLYMORPHISM
      • 8.5.1.1. AFLP technique to witness the highest growth rate in the capillary electrophoresis market during the forecast period
    • 8.5.2. RESTRICTION FRAGMENT LENGTH POLYMORPHISM
      • 8.5.2.1. Increasing demand for RFLP from forensics, agricultural institutions, and pharmaceutical and biotechnology companies-major factor driving market growth
    • 8.5.3. SINGLE-STRAND CONFORMATION POLYMORPHISM
      • 8.5.3.1. Increasing applications of SSCP in virology are expected to play a key role in the growth of the SSCP market
  • 8.6. MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT (MALDI-TOF) MASS SPECTROMETRY
    • 8.6.1. INCREASING APPLICATIONS OF THIS TECHNIQUE IN CLINICAL DIAGNOSTICS AND PHARMACOGENOMICS TO DRIVE MARKET GROWTH
  • 8.7. OTHER TECHNOLOGIES

9. GENOTYPING MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. PHARMACOGENOMICS
    • 9.2.1. PHARMACOGENOMICS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOTYPING MARKET IN 2017
  • 9.3. DIAGNOSTICS & PERSONALIZED MEDICINE
    • 9.3.1. TECHNOLOGICAL ADVANCEMENTS AND INCREASING POTENTIAL OF DEVELOPING DIAGNOSTICS TESTS THROUGH RAPID GENOTYPING TECHNIQUES ARE THE KEY FACTORS DRIVING THE GROWTH OF THIS APPLICATION SEGMENT
  • 9.4. ANIMAL GENETICS
    • 9.4.1. LOWER ADOPTION OF GENOTYPING TECHNOLOGIES IN ANIMAL BREEDING PROGRAMS IN DEVELOPING COUNTRIES TO RESTRAIN THE GROWTH OF THIS SEGMENT
  • 9.5. AGRICULTURAL BIOTECHNOLOGY
    • 9.5.1. INCREASING NUMBER OF RESEARCH LABORATORIES AND GREENHOUSES USING PLANT GENOTYPING AND CONTINUOUS PRODUCT INNOVATIONS AND NEW PRODUCT LAUNCHES ARE DRIVING THE GROWTH OF THE AGRICULTURAL BIOTECHNOLOGY SEGMENT
  • 9.6. OTHER APPLICATIONS

10. GENOTYPING MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • 10.2.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 10.3. DIAGNOSTIC & RESEARCH LABORATORIES
    • 10.3.1. GROWING PREFERENCE FOR PERSONALIZED MEDICINE AND INCREASING RESEARCH FOCUSED ON PERSONALIZED DIAGNOSIS ARE THE KEY FACTORS DRIVING MARKET GROWTH
  • 10.4. ACADEMIC INSTITUTES
    • 10.4.1. INCREASING RESEARCH ACTIVITIES FOR DRUG DISCOVERY AND RISING INDUSTRY-ACADEMIA COLLABORATIONS FOR DRUG DEVELOPMENT ARE THE KEY FACTORS DRIVING MARKET GROWTH
  • 10.5. OTHER END USERS

11. GENOTYPING MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
      • 11.2.1.1. US dominated the North American genotyping market in 2018; this trend to continue during the forecast period
    • 11.2.2. CANADA
      • 11.2.2.1. Increasing incidence of genetic diseases & the availability of a wide range of genotyping products to drive market growth in Canada
  • 11.3. EUROPE
    • 11.3.1. GERMANY
      • 11.3.1.1. Germany accounted for the largest share of the European genotyping market in 2017
    • 11.3.2. FRANCE
      • 11.3.2.1. Increasing incidence of genetic disorders & growing public-private investments are driving the growth of the genotyping market in France
    • 11.3.3. UK
      • 11.3.3.1. UK to witness the highest growth in the European genotyping market during the forecast period
    • 11.3.4. ITALY
      • 11.3.4.1. Presence of a well-developed healthcare system and rapid growth in the geriatric population are key factors driving market growth in Italy
    • 11.3.5. SPAIN
      • 11.3.5.1. The lingering effect of economic downturns will continue to affect healthcare in Spain
    • 11.3.6. REST OF EUROPE
  • 11.4. ASIA PACIFIC
    • 11.4.1. CHINA
      • 11.4.1.1. Infrastructural improvements in China's healthcare system have boosted treatment rates and care delivery
    • 11.4.2. JAPAN
      • 11.4.2.1. Strong base of pharmaceutical activity will contribute to the use of genotyping
    • 11.4.3. INDIA
      • 11.4.3.1. Growth of the pharmaceutical industry has highlighted the need for better infrastructure in India
    • 11.4.4. REST OF APAC
  • 11.5. LATIN AMERICA
  • 11.6. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. PRODUCT PORTFOLIO MATRIX
  • 12.3. MARKET SHARE ANALYSIS
  • 12.4. COMPETITIVE SITUATIONS AND TRENDS
    • 12.4.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 12.4.2. ACQUISITIONS
    • 12.4.3. EXPANSIONS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. ILLUMINA, INC.
  • 13.2. THERMO FISHER SCIENTIFIC, INC.
  • 13.3. ROCHE DIAGNOSTICS LIMITED
  • 13.4. QIAGEN N.V.
  • 13.5. DANAHER CORPORATION
  • 13.6. AGILENT TECHNOLOGIES, INC.
  • 13.7. FLUIDIGM CORPORATION
  • 13.8. GE HEALTHCARE
  • 13.9. GENEWIZ, INC.
  • 13.10. INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
  • 13.11. PERKINELMER, INC.
  • 13.12. BIO-RAD LABORATORIES, INC.
  • 13.13. EUROFINS SCIENTIFIC
  • 13.14. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORT
  • 14.6. AUTHOR DETAILS
Back to Top
전화 문의
이용안내
 
BCC Research